References
- Leung TY, Chan LW, Leung TN, Fung TY, Sahota DS, Spencer K, Lau TK. First-trimester combined screening for trisomy 21 in a predominantly Chinese population. Ultrasound Obstet Gynecol 2007;29:14–17.
- Leung TY, Chan LW, Law LW, Sahota DS, Fung TY, Leung TN, Lau TK. First trimester combined screening for Trisomy 21 in Hong Kong: outcome of the first 10,000 cases. J Matern Fetal Neonatal Med 2009;22:300–304.
- Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008;31:618–624.
- Sahota DS, Leung TY, Chan LW, Law LW, Fung TY, Chen M, Lau TK. Comparison of first-trimester contingent screening strategies for Down syndrome. Ultrasound Obstet Gynecol 2010;35:286–291.
- Benn PA, Collins R. Evaluation of effect of analytical imprecision in maternal serum screening for Down’s syndrome. Ann Clin Biochem 2001;38:28–36.
- Down’s Syndrome Quality Assurance Support Service (DQASS). QA of the MOM letter. Available at: http://fetalanomaly.screening.nhs.uk/getdata.php?id = 10707. Accessed on January 2, 2009.
- Schmidt P, Staboulidou I, Elsässer M, Vaske B, Hillemanns P, Scharf A. How imprecise may the measurement of fetal nuchal translucency be without worsening first-trimester screening? Fetal Diagn Ther 2008;24:291–295.
- Kagan KO, Wright D, Etchegaray A, Zhou Y, Nicolaides KH. Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21. Ultrasound Obstet Gynecol 2009;33:657–664.
- ACOG Practice Bulletin. Screening for fetal chromosomal abnormalities. Number 77, January 2007.
- Chan YM, Sahota DS, Chan OK, Leung TY, Lau TK. A survey of prenatal first-trimester aneuploidy screening among Hong Kong specialist obstetricians. Hong Kong Med J 2009;15:447–451.
- D’Alton ME, Cleary-Goldman J, Lambert-Messerlian G, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial. Ultrasound Obstet Gynecol 2009;33:142–146.
- Cuckle H. Monitoring quality control of nuchal translucency. Clin Lab Med 2010;30:593–604.
- Sahota DS, Chen M, Leung TY, Chan LW, Fung TY, Ting YH, Lau TK. Assessment of sonographer nuchal translucency measurement performance–central tendency and dispersion. J Matern Fetal Neonatal Med 2011;24:812–816.
- Sahota DS, Leung TY, Fung TY, Chan LW, Law LW, Lau TK. Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21. Ultrasound Obstet Gynecol 2009;33:387–393.
- Hawkins DM, Olwell DH. Cumulative Sum Charts and Charting for Quality Improvement. Statistics for engineering and physical science. New York: Springer-Verlag, 1998.
- ‘AnygetH.exe’. Available at: http://www.stat.umn.edu/cusum/software.htm. Accessed on 20 November, 2010.
- Wøjdemann KR, Christiansen M, Sundberg K, Larsen SO, Shalmi A, Tabor A. Quality assessment in prospective nuchal translucency screening for Down syndrome. Ultrasound Obstet Gynecol 2001;18:641–644.
- Fries N, Althuser M, Fontanges M, Talmant C, Jouk PS, Tindel M, Duyme M. Quality control of an image-scoring method for nuchal translucency ultrasonography. Am J Obstet Gynecol 2007;196:272.e1–272.e5.
- Biau DJ, Porcher R, Salomon LJ. CUSUM: a tool for ongoing assessment of performance. Ultrasound Obstet Gynecol 2008;31:252–255.
- Sabrià J, Barceló-Vidal C, Arigita M, Jimenez JM, Puerto B, Borrell A. The CUSUM test applied in prospective nuchal translucency quality review. Ultrasound Obstet Gynecol 2011;37:582–587.